[ad_1]
Topline
Dr Anthony Fauci suggested in an interview on Sunday morning that the Trump administration could have been more aggressive in its initial negotiations with vaccine makers to avoid supply shortages that have since emerged as the biggest obstacle to deployment. vaccines.
Dr Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, speaks … [+]
Getty Images
Highlights
Fauci, a senior infectious disease official involved in the Trump and Biden administrations’ pandemic response, told NBC “Meet the Press” that if a dose shortage was “in some ways” inevitable, the United States could have get more when he had the chance.
“We certainly could have, I guess, contracted a little more aggressively with the companies to get more doses,” Fauci said, adding, “But at the moment, that’s what we have.”
Fauci called the lack of supply to meet booming demand the biggest difficulty of the deployment to date, describing it as a “limiting factor.”
Key context
The Trump administration secured a total of 400 million doses of Moderna, Pfizer, and BioNtech, with final purchases made in late December 2020. The former president sparked strong reactions late last year when The New York Times reported that the Trump administration had turned down the option of obtaining additional doses of Pfizer, a report administration officials chided. The Biden administration is currently negotiating to obtain 100 million additional doses from Pfizer and BioNTech and 100 million from Moderna. Fauci predicted that inoculations would increase sharply over the next few months, as further doses of Pfizer and Moderna are expected to arrive in March and April, and, last week, Johnson & Johnson requested emergency clearance of their Covid from single dose. 19 vaccine.
Large number
30.8 million. That’s the number of Americans who have received at least one dose of the coronavirus vaccine. About 9% of the U.S. population and 25% of the priority population have received at least one stroke, according to data compiled by The Washington Post.
Comprehensive coverage and live updates on the coronavirus
Source link
